Halozyme Therapeutics
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell HALO and other ETFs, options, and stocks.About HALO
Halozyme Therapeutics, Inc. is a biopharmaceutical technology platform company. It engages in developing, manufacturing, and commercializing drug-device combination products using advanced auto-injector technology that are designed to provide commercial or functional advantages such as improved convenience and tolerability, and enhanced patient comfort and adherence.
HALO Key Statistics
Stock Snapshot
Halozyme Therapeutics(HALO) stock is priced at $115.54, giving the company a market capitalization of 13.07B. It carries a P/E multiple of 33.59.
During the trading session on 2026-09-25, Halozyme Therapeutics(HALO) shares reached a daily high of $115.54 and a low of $115.54. At a current price of $115.54, the stock is 0.0% higher than the low and still 0.0% under the high.
Trading activity shows a volume of 706, compared to an average daily volume of 2.96M.
Over the past 52 weeks, Halozyme Therapeutics(HALO) stock has traded between a high of $116.85 and a low of $61.23.
Over the past 52 weeks, Halozyme Therapeutics(HALO) stock has traded between a high of $116.85 and a low of $61.23.
HALO News
Advertisement Convertible notes offering reframes the Halozyme Therapeutics funding story Halozyme Therapeutics (HALO) has just closed a US$1.3b convertible n...
An update from Halozyme ( (HALO) ) is now available. On September 22, 2026, Halozyme Therapeutics completed a $1.5 billion private offering of 1.50% Convertibl...
Analyst ratings
73%
of 11 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.